Capa, Ma. Cassandra P.
HRN: 17-01-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2022
CEFTRIAXONE 1G (VIAL)
11/21/2022
11/28/2022
IVT
1,250 Mg
24 Hrs
UTI; R/o Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes